Director & 10% Owner Gregg Williams Buys Another $2M in Vivani Medical Stock
VANI sits 25% above its 52-week low of $0.923.
Summary
Director and 10% owner Gregg Williams made another substantial open-market purchase of Vivani Medical stock, investing nearly $2 million and continuing a pattern of significant insider accumulation.
Key Events · Ownership and Investor Activity · VANI
-
Significant Insider Purchase
Gregg Williams, a Director and 10% owner, purchased 1,587,301 shares of common stock for $1,999,999.26 at a price of $1.26 per share on June 15, 2026.
-
Continued Insider Accumulation
This transaction extends a pattern of substantial insider buying by Gregg Williams, following previous purchases of approximately $2 million in April and May, and an announced acquisition of $3 million in May.
-
Strong Conviction Signal
The $2 million investment represents over 2% of the company's market capitalization, indicating strong insider confidence, especially after recent positive clinical trial results for its GLP-1 implant.
Analysis · VANI · Industrial Applications And Services
Gregg Williams, a Director and 10% owner, continues to show strong conviction in Vivani Medical by purchasing an additional $2 million worth of common stock. This significant investment, representing over 2% of the company's market capitalization, extends a pattern of substantial insider accumulation over the past few months. Such repeated large purchases by a key insider often indicate a belief in the company's future prospects, especially following recent positive clinical trial results and capital raises.
At the time of this filing, VANI was trading at $1.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $97.4M. The 52-week trading range was $0.92 to $1.92. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.